Arcus Biosciences Files 2024 10-K
Ticker: RCUS · Form: 10-K · Filed: Feb 25, 2025 · CIK: 1724521
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
Arcus Bio's 2024 10-K is in. Full financials and biz ops detailed.
AI Summary
Arcus Biosciences, Inc. filed its 2024 10-K on February 25, 2025, reporting on its fiscal year ending December 31, 2024. The company, focused on pharmaceutical preparations, is based in Hayward, California. Key financial details and business operations for the period are outlined in this comprehensive filing.
Why It Matters
This filing provides investors and stakeholders with a detailed overview of Arcus Biosciences' financial health, operational performance, and strategic direction for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Arcus Biosciences faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024 — Fiscal Year (Reporting period for the 10-K)
- 1231 — Fiscal Year End (December 31st is the end of the reporting period)
Key Players & Entities
- Arcus Biosciences, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-02-25 (date) — Filing date
- Hayward, CA (location) — Company headquarters
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What is the primary business of Arcus Biosciences, Inc.?
Arcus Biosciences, Inc. is primarily involved in Pharmaceutical Preparations, as indicated by its SIC code 2834.
When was the 10-K filing for the fiscal year 2024 submitted?
The 10-K filing for the fiscal year 2024 was submitted on February 25, 2025.
Where is Arcus Biosciences, Inc. headquartered?
Arcus Biosciences, Inc. is headquartered at 3928 Point Eden Way, Hayward, CA 94545.
What is the SEC file number for Arcus Biosciences?
The SEC file number for Arcus Biosciences is 001-38419.
What is the fiscal year end date for Arcus Biosciences?
The fiscal year end date for Arcus Biosciences is December 31 (1231).
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 25, 2025 regarding Arcus Biosciences, Inc. (RCUS).